Effects of Silybum Marianum on Treatment of Patients With Chronic Hepatitis C
Effects of Silybum Marianum on Treatment of Patients With Chronic Hepatitis C
The purpose of this study is to determine the effects of silymarin on outcomes of patients
 with hepatitis C.
Silymarin has been claimed to have a beneficial effect in various types of liver injury,
 including alcoholic liver disease, drug and toxin induced hepatotoxicity, and acute and
 chronic viral hepatitis.
Inclusion Criteria:

 confirmed chronic hepatitis C (HCV Ab (+), HCV RNA (with PCR) (+)) normal or increased
 liver enzymes (ALT and AST) not using interferon or ribavirin due to patient sensitivity or
 not consenting.

 Exclusion Criteria:

 The pregnant patients patients with side effect which confirmed with rechallenge test